Oncolytics Biotech Inc. ONCY

Set alert

Price alert · ONCY

All alert types
0.40 USD 0.00 -0.98%

As of Nov 3, 12:16 PM ET

Bid
0.39 × 1
Ask
0.40 × 5
0.392 Day range 0.4072
0.395 52-week range 1.27
YTD
-54.47%
1 year
-63.66%
Open
0.40
Prev close
0.40
Mkt cap
51.79M
Vol
275.24K
Avg vol
1.04M
EPS
-0.35
P/E
0.00
Div yield
0.00%
More statistics
Low
0.392
High
0.4072
Forward P/E
-3.02
Beta
1.51
Short ratio
3.51
Inst. own
1.76%
Dividend
0.00
Ex-div date
50-d avg
1.04
200-d avg
1.04
1y target
4.85

5D chart

Chart tools
Interval

Signals (117)
NameTimeAgo
MACD: Sell SignalNov 2, 12:45 PM23 hours ago
MACD: Buy SignalNov 2, 12:40 PM23 hours ago
SMA: BearishNov 2, 11:50 AM1 day ago
SMA: BullishNov 2, 11:45 AM1 day ago
SMA: BearishNov 2, 10:55 AM1 day ago
SMA: BearishNov 2, 10:50 AM1 day ago
SMA: BullishNov 2, 10:45 AM1 day ago
SMA: BullishNov 2, 10:45 AM1 day ago
SMA: BearishNov 2, 10:30 AM1 day ago
SMA: BullishNov 2, 10:25 AM1 day ago
SMA: BearishNov 2, 10:05 AM1 day ago
SMA: BullishNov 2, 10:00 AM1 day ago
SMA: BearishNov 2, 9:50 AM1 day ago
MACD: Sell SignalNov 2, 9:50 AM1 day ago
SMA: BearishNov 2, 9:40 AM1 day ago
RSI: OverboughtOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:40 PM3 days ago
SMA: BearishOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:30 PM3 days ago
SMA: BullishOct 30, 3:30 PM3 days ago

Newest 20 of 117.

Analyst view

Price target (mean) 4.85
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ONCY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.1345-0.139 – -0.13-0.111-21.2%00.0%2
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-0.40667-0.43 – -0.38-0.489+16.8%00.0%3
Next year-0.4665-0.54 – -0.36-0.40667-14.7%857.14K0.0%4

Upgrades and downgrades

The latest rating changes

ONCY analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 4, 2024Raymond JamesInitiated—Outperform
Mar 8, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 16, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 29, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 23, 2023Canaccord GenuityReiteratedBuyBuy
Jun 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 26, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 24, 2023JonesTradingInitiated—Buy
Mar 14, 2023HC Wainwright & Co.Reiterated—Buy
Mar 6, 2023Canaccord GenuityMaintained—Buy
Oct 6, 2022Maxim GroupInitiated—Buy
Feb 17, 2021HC Wainwright & Co.Initiated—Buy
May 11, 2020RBC CapitalMaintained—Outperform
Sep 12, 2013NeedhamInitiated—Buy
Mar 4, 2013Piper SandlerInitiated—Overweight
Dec 18, 2012Bloom Burton & Co.DowngradeBuyHold
Sep 12, 2012Bloom Burton & Co.Maintained—Buy
Aug 30, 2012StifelInitiated—Buy